admin

admin

Gilead Snaps Up Tubulis, German Oncology Firm, in $5B Deal

On Tuesday, Gilead, a US-based pharmaceutical corporation, revealed its intention to purchase the privately owned German entity, Tubulis GmbH, for a sum reaching $5 billion. This agreement is intended to broaden the corporation’s collection with a hopeful category of investigational…